Borel Tocilizumab in patients with severe COVID-1
Post# of 148181
(Total Views: 632)
Posted On: 07/06/2020 1:28:23 PM
Re: Borel Fields #41267
Borel Tocilizumab in patients with severe COVID-19: a retrospective cohort study.
https://www.thelancet.com/journals/lanrhe/art...9/fulltext
Also existing trial, primary endpoint completion estimated June 30 2020
https://clinicaltrials.gov/ct2/show/NCT043569...mp;rank=11
Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 278 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Prospective, multi-center, randomized,double blind, placebo-controlled trial
Masking: Double (Participant, Investigator)
Masking Description: Subjects who meet all inclusion criteria and none of the exclusion criteria will be randomized 2:1 to tocilizumab or placebo.
Primary Purpose: Treatment
Official Title: Tocilizumab to Prevent the Progression of Hypoxemic Respiratory Failure in Hospitalized Non-Critically Ill Patients With COVID-19
Actual Study Start Date : April 20, 2020
Estimated Primary Completion Date : June 30, 2020
Estimated Study Completion Date : August 30, 2020
https://www.thelancet.com/journals/lanrhe/art...9/fulltext
Also existing trial, primary endpoint completion estimated June 30 2020
https://clinicaltrials.gov/ct2/show/NCT043569...mp;rank=11
Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 278 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Prospective, multi-center, randomized,double blind, placebo-controlled trial
Masking: Double (Participant, Investigator)
Masking Description: Subjects who meet all inclusion criteria and none of the exclusion criteria will be randomized 2:1 to tocilizumab or placebo.
Primary Purpose: Treatment
Official Title: Tocilizumab to Prevent the Progression of Hypoxemic Respiratory Failure in Hospitalized Non-Critically Ill Patients With COVID-19
Actual Study Start Date : April 20, 2020
Estimated Primary Completion Date : June 30, 2020
Estimated Study Completion Date : August 30, 2020
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼